Polaryx Therapeutics, Inc. - 8-K Filing
Polaryx Therapeutics stockholders elected two Class I directors and ratified Grant Thorton LLP as auditor at the September 10 annual meeting. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $PLYX